Comparing two ways to give terlipressin for variceal bleeding
Part of Digestive system clinical trials.
This study tests whether giving terlipressin continuously through an IV works better and is safer than giving it as a series of injections to stop bleeding from swollen veins in the esophagus. It is for people with acute-on-chronic liver failure (ACLF), a serious condition where the liver suddenly gets much worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with acute-on-chronic liver failure (ACLF).
- You have bleeding from swollen veins in your esophagus (variceal bleed).
- You do not have heart disease, asthma, epilepsy, or a history of stroke.
- You are not pregnant, do not have liver cancer, and have not already had rebleeding.
- Your bleeding is not from varices in the stomach.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a slightly different target on a blood-clotting test (ROTEM) can reduce the need for blood transfusions in people with liver disease who need a procedure. If you have cirrhosis or ACLF with severe clotting problems, this study may help your doctors decide how much blood product to give you before the procedure.
This study compares two ways to prevent bleeding from enlarged veins in the esophagus (varices) in people with liver cancer and cirrhosis. One method uses a medication called carvedilol alone, while the other combines carvedilol with a procedure called band ligation, which ties off the veins to prevent bleeding.
This study compares two timings for doing an endoscopy (a tube with a camera to look at your food pipe and stomach) for people with advanced liver disease who have bleeding from swollen veins. It aims to see if doing it right away is better than waiting a bit, to help stop bleeding and improve recovery.
This trial tests whether a pill (dabigatran) or a daily injection (enoxaparin) is better at preventing new blood clots in the liver vein for people with cirrhosis. Both are blood thinners, and the study wants to see which one is safer and more effective.
This trial compares two medicines, terlipressin and somatostatin, to see which one better controls bleeding from enlarged veins in the esophagus or stomach in people with cirrhosis and kidney problems. The goal is to find a safer and more effective treatment for this serious condition.
This study compares two ways to prevent future bleeding from enlarged veins in the esophagus or stomach in people with liver cirrhosis. One method uses a small tube (called TIPS) to reduce pressure in the liver, and the other combines a banding procedure with medication. The goal is to see which approach works better.
Hear when a new Acute-On-Chronic Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.